HERCEPTIN (Trastuzumab)150 MG &440 MG

HERCEPTIN (Trastuzumab)150 MG &440 MG

Open this result in new window
Herceptin (trastuzumab) is part of a treatment plan for the adjuvant treatment of patients with HER2 overexpressing, node-positive HER2+ breast cancer.
United Kingdom
Herceptin

Herceptin

Open this result in new window
Trastuzumab (Herceptin) is a monoclonal antibody that interferes with the HER2/ neu receptor. The HER receptors are proteins that are embedded in the cell membrane and communicate molecular signals from outside the cell to inside the cell, and turn ...
India
Google
Advertisement
Email this page Bookmark and Share